dlt446 dlt446

dlt446 dlt446

Clinical Professor

Member of:

  • Neurology


  1. 2021
  2. Published

    Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study: [Correction]

    Amin, Faisal Mohammad, De Icco, R., Al-Karagholi, M. A. M., Raghava, J., Wolfram, F., Larsson, Henrik Bo Wiberg & dlt446, dlt446, 2021, In: Journal of Headache and Pain. 22, 98.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers

    Ghanizada, H., Iljazi, A., Ashina, H., Do, T. P., Al-Karagholi, M. A. M., Amin, Faisal Mohammad & dlt446, dlt446, 2021, In: Cephalalgia. 41, 1, p. 99-111 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Opening of ATP sensitive potassium channels causes migraine attacks with aura

    Al-karagholi, M. A., Ghanizada, H., Nielsen, C. A. W., Hougaard, A. & dlt446, dlt446, 2021, In: Brain. 144, 8, p. 2322-2332 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine

    Al-Karagholi, M. A., Ghanizada, H., Waldorff Nielsen, C. A., Skandarioon, C., Snellman, J., Lopez-Lopez, C., Hansen, J. M. & dlt446, dlt446, 2021, In: Pain. 162, 10, p. 2512-2520

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    PEARL study protocol: A real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine

    dlt446, dlt446, Amin, Faisal Mohammad, Kokturk, P., Cohen, J. M., Konings, M., Tassorelli, C., Lyras, L. & Mitsikostas, D. D., 2021, In: Pain Management. 11, 6, p. 647-654

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers

    Al-Karagholi, M. A., Hansen, J. M., Abou-Kassem, D., Hansted, A. K., Ubhayasekera, K., Bergquist, J., Vécsei, L., Jansen-Olesen, I. & dlt446, dlt446, 2021, In: Pharmacology Research & Perspectives. 9, 2, p. 1-10 e00741.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

    dlt446, dlt446, Reuter, U., Smith, T., Krikke-Workel, J., Klise, S. R., Bragg, S., Doty, E. G., Dowsett, S. A., Lin, Q. & Krege, J. H., 2021, In: Cephalalgia. 41, 3, p. 294-304 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials

    Tepper, S. J., dlt446, dlt446, Reuter, U., Hallström, Y., Broessner, G., Bonner, J. H., Picard, H., Cheng, S., Chou, D. E., Zhang, F., Klatt, J. & Mikol, D. D., 2021, In: Journal of Headache and Pain. 22, 81.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020

    Schytz, Henrik Winther, Amin, Faisal Mohammad, Jensen, Rigmor Højland, Carlsen, L., Maarbjerg, S., Lund, N., Aegidius, K., Thomsen, L. L., Bach, F. W., Beier, D., Johansen, H., Hansen, J. M., Kasch, H., Munksgaard, S. B., Poulsen, L., Sørensen, P. S., Schmidt-Hansen, P. T., Cvetkovic, V. V., dlt446, dlt446 & Bendtsen, Lars, 2021, In: Journal of Headache and Pain. 22, 22.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension

    Lipton, R. B., Tepper, S. J., Silberstein, S. D., Kudrow, D., dlt446, dlt446, Reuter, U., Dodick, D. W., Zhang, F., Rippon, G. A., Cheng, S. & Mikol, D. D., 2021, In: Cephalalgia. 41, 1, p. 6-16 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 920785